Suwa Maternity Clinic to close its infertility treatment outpatient service in March next year… The clinic previously announced Japan’s first surrogacy case and performed selective reduction surgeries – Yomiuri Shimbun

News Highlights

Suwa Maternity Clinic, which has long contributed to regional healthcare in Suwa City, Nagano Prefecture, will close its infertility treatment outpatient service as of March 2025. The clinic has been a pioneering medical institution, having announced Japan’s first case of surrogacy and performed procedures such as selective reduction surgery for multiple pregnancies. The closure of this outpatient service may impact access to infertility treatment in the region.

M&A Medical Editorial Department’s Perspective

The closure of Suwa Maternity Clinic’s infertility treatment outpatient service is not merely the end of a single facility, but highlights the broader challenge of maintaining highly specialized outpatient services within regional healthcare. The fact that the clinic, known for its advanced initiatives such as announcing Japan’s first surrogacy case, has decided to discontinue its infertility treatment outpatient service due to management decisions is significant. Factors such as a lack of successors and the concentration of management resources are presumed, but this will force patients who have relied on the clinic, particularly those seeking advanced reproductive medicine, to seek new options in neighboring areas. This can be seen as a typical example of how individual management issues of medical institutions directly impact the regional healthcare delivery system.

Points Raised by This News

• The closure of an infertility treatment outpatient service at a clinic providing advanced medical care suggests a risk of creating healthcare deserts in the region.
• The management decision by a medical institution that produced Japan’s first case serves as a warning to the business continuity of the entire industry.
• Concerns about the widening access gap in highly specialized fields like infertility treatment across different regions.
• Business succession and M&A considerations for medical institutions are essential options for maintaining and developing highly specialized outpatient services.

Practical Questions Arising from This News

• How will existing infertility treatment patients be accommodated after the closure?
• What will be the future treatment system for the clinic’s other departments (obstetrics and gynecology)?
• Which medical institutions in Nagano Prefecture and surrounding areas offer advanced infertility treatments?

If You Feel “Should I Consult Too?”

The closure of the infertility treatment outpatient service at a long-established and trusted medical institution like Suwa Maternity Clinic should be viewed as a potential management challenge that could occur at your own clinic in the future. Especially when providing advanced specialized medical care, issues with successor physicians or limitations in management resources can lead to a situation where one is forced to abandon contributions to regional healthcare. By consulting with specialists early and considering options such as third-party succession or M&A, a path can be found to minimize the impact on patients and continue to keep the light of regional healthcare burning.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics as a business succession support institution certified by the Small and Medium Enterprise Agency, with a full success fee system. Consultations are accepted with strict confidentiality. Free consultations are available here.